On ECHEMI
Home > Drugs > Henoch-Schonlein purpura nephritis in children
Henoch-Schonlein purpura nephritis in children
Henoch-Schonlein purpura nephritis (HSP) in children is a clinical syndrome characterized by skin purpura, hemorrhagic gastroenteritis, arthritis and glomerulonephritis. Henoch-Schonlein purpura nephritis is an allergic disease associated with vascular autoimmune damage and with small vessel inflammation as the main lesion. Its basic lesions are IgA deposition in the glomerular mesangial area and mesangial cell proliferation with or without crescent formation. Renal damage often occurs within 3 months of the onset of skin purpura (95%). Although there are reports that renal damage can occur before skin purpura and 1 year after skin purpura, renal damage that occurs after 6 months should generally not be easily regarded as purpuric nephritis. About half of HSP children develop renal damage, which is called anaphy lactoid purpura nephritis.
  • Site of disease:

    Kidney immune system blood vessels
  • Infectious :

    Not contagious
  • Frequent population:

    child
  • Related symptoms:

    Petechiae rash proteinuria nausea and vomiting epistaxis proteinuria
  • Concurrent disease:

Related Drugs
Cimetidine injection
Indication: This product is suitable for: 1. Treatment of clearly diagnosed duodenal ulcer and gastric ulcer; 2. Patients with recurrence of intestinal ulcer after short-term treatment; 3. Patients with persistent gastroesophageal reflux disease who are ineffective with anti-reflux measures and single drug treatment such as antacids; 4. Prevention of stress ulcer and bleeding in critically ill patients; 5. Gastrinoma (Zollinger-Ellison syndrome).
Manufacturer:

Henan Kelun Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.